Telitacicept Ph III Succeeds in Primary Sjögren’s Syndrome
13 Aug 2025 //
PR NEWSWIRE
Telitacicept Hits Phase 3 Goal in Primary Sjögren`s Disease Study
13 Aug 2025 //
GLOBENEWSWIRE
RemeGen`s Telitacicept (RC18) Received Orphan Drug Designation
17 Jun 2025 //
PR NEWSWIRE